Literature DB >> 20512337

Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis.

A F Christensen1, S V Hoegh, T Lottenburger, U Holmskov, I Tornoe, K Hørslev-Petersen, G L Sørensen, P Junker.   

Abstract

Surfactant protein D (SP-D) belongs to the collectin family and has pro-and anti-inflammatory capacities depending on its oligomerization. Previously, circulating SP-D was shown to be decreased in early rheumatoid arthritis (RA) and negatively correlated to disease activity. This study aimed at assessing the diurnal rhythmicity and the influence of physical activity on circulating SP-D in patients with RA at different stages compared with healthy individuals. Patients with early RA (ERA) with disease duration <6 months and with long-standing RA (LRA) with disease duration 5-15 years were included in two sub-studies. Healthy individuals served as controls. Diurnal variation: blood samples were collected every 3 h from 7 a.m to 10 p.m and the following morning. Physical activity: blood sampling was done before and after standardized physical challenge. SP-D was measured by ELISA. SP-D exhibited diurnal variation in healthy controls (n = 15) and in patients with ERA (n = 9) and LRA (n = 9) with peak values at 10 a.m. and nadir in the evening (controls: P < 0.001, ERA: P = 0.004 and LRA: P = 0.009). Three hours after cessation of physical activity, SP-D decreased below pre-exercise levels in both ERA (n = 10), LRA (n = 10) and controls (n = 13) (ERA: P < 0.001, LRA: P < 0.001 and controls: P = 0.005). In patients with RA, the decline was already observed 1 h post-exercise. Circulating SP-D exhibits diurnal variation both in patients with RA at different stages and in healthy controls. SP-D in serum decreases following physical activity in health and RA disease. This study underscores the need of standardized blood sampling conditions in future studies on SP-D.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512337     DOI: 10.1007/s00296-010-1538-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  41 in total

Review 1.  Lung epithelium-specific proteins: characteristics and potential applications as markers.

Authors:  C Hermans; A Bernard
Journal:  Am J Respir Crit Care Med       Date:  1999-02       Impact factor: 21.405

2.  Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells.

Authors:  E Crouch; D Parghi; S F Kuan; A Persson
Journal:  Am J Physiol       Date:  1992-07

3.  Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa.

Authors:  Minjian Ni; David J Evans; Samuel Hawgood; E Margot Anders; Robert A Sack; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome.

Authors:  J Y Wang; T F Yeh; Y C Lin; K Miyamura; U Holmskov; K B Reid
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

5.  A role for surfactant protein D in innate immunity of the human prostate.

Authors:  Rebecca E Oberley; Kelli L Goss; Laila Dahmoush; Kevin A Ault; Erika C Crouch; Jeanne M Snyder
Journal:  Prostate       Date:  2005-11-01       Impact factor: 4.104

6.  Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison.

Authors:  M Cutolo; G J M Maestroni; K Otsa; O Aakre; B Villaggio; S Capellino; P Montagna; L Fazzuoli; T Veldi; T Peets; E Hertens; A Sulli
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

7.  Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia.

Authors:  Rikke Leth-Larsen; Claudia Nordenbaek; Ida Tornoe; Vivi Moeller; Anders Schlosser; Claus Koch; Boerge Teisner; Peter Junker; Uffe Holmskov
Journal:  Clin Immunol       Date:  2003-07       Impact factor: 3.969

8.  Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells.

Authors:  Gary D Snyder; Rebecca E Oberley-Deegan; Kelli L Goss; Sara A Romig-Martin; Lynn L Stoll; Jeanne M Snyder; Neal L Weintraub
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-21       Impact factor: 4.733

9.  Surfactant protein D in the female genital tract.

Authors:  R Leth-Larsen; C Floridon; O Nielsen; U Holmskov
Journal:  Mol Hum Reprod       Date:  2004-01-29       Impact factor: 4.025

10.  Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity.

Authors:  José Manuel Fernández-Real; Sergio Valdés; Melania Manco; Berta Chico; Patricia Botas; Arantza Campo; Roser Casamitjana; Elías Delgado; Javier Salvador; Gema Fruhbeck; Geltrude Mingrone; Wifredo Ricart
Journal:  Diabetes Care       Date:  2010-01-19       Impact factor: 19.112

View more
  4 in total

Review 1.  Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury.

Authors:  Patricia Silveyra; Joanna Floros
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

Review 2.  Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.

Authors:  Sofie Lock-Johansson; Jørgen Vestbo; Grith Lykke Sorensen
Journal:  Respir Res       Date:  2014-11-25

Review 3.  Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Authors:  Grith L Sorensen
Journal:  Front Med (Lausanne)       Date:  2018-02-08

4.  Endurance exercise training decreased serum levels of surfactant protein D and improved aerobic fitness of obese women with type-2 diabetes.

Authors:  Sajjad Rezaei; Mahdieh Molanouri Shamsi; Mehdi Mahdavi; Azadeh Jamali; Jonato Prestes; Ramires Alsamir Tibana; James Wilfred Navalta; Fabrício Azevedo Voltarelli
Journal:  Diabetol Metab Syndr       Date:  2017-09-25       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.